Methamphetamine Abuse Treatment in Patients With AIDS - 1 - Full Text View

Methamphetamine Abuse Treatment in Patients With AIDS - 1

This study has been completed.

Sponsors and Collaborators:	National Institute on Drug Abuse (NIDA) Friends Research Institute, Inc.
Information provided by:	National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov Identifier:	NCT00000321

Purpose

The purpose of this study is to evaluate the efficacy of desipramine, sertraline, and placebo on methamphetamine dependent gay men with AIDS.

Condition	Intervention	Phase
Substance-Related Disorders	Drug: Desipramine	Phase IV

MedlinePlus related topics:

Methamphetamine

Drug Information available for:

Desipramine Desipramine hydrochloride Methamphetamine

U.S. FDA Resources

Study Type:	Interventional
Study Design:	Treatment

Official Title:	Methamphetamine Abuse Pharmacology in Patients With AIDS

Further study details as provided by National Institute on Drug Abuse (NIDA):

Primary Outcome Measures:

Craving
Retention
Depression
Methamphetamine use
Anxiety and Depression
ASI Scales (7)
AIDS medical care engagement
High risk sexual behaviors
Mood indicators

Estimated Enrollment:	0
Study Start Date:	October 1996
Estimated Study Completion Date:	December 2001

Eligibility

Genders Eligible for Study:	Male
Accepts Healthy Volunteers:	No

Criteria

Please contact site for information.

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00000321

Locations


United States, California
	Friends Research Institute
	Los Angeles, California, United States, 90025

Sponsors and Collaborators

National Institute on Drug Abuse (NIDA)

Friends Research Institute, Inc.

Investigators


Principal Investigator:	Frank Gawin, M.D.	Friends Research Institute, Inc.

More Information

Study ID Numbers:	NIDA-10643-1, R01-10643-1
First Received:	September 20, 1999
Last Updated:	August 16, 2005
ClinicalTrials.gov Identifier:	NCT00000321
Health Authority:	United States: Federal Government

Study placed in the following topic categories:

Methamphetamine

Dopamine

Mental Disorders

Substance-Related Disorders

Disorders of Environmental Origin

Desipramine

Additional relevant MeSH terms:

Dopamine Uptake Inhibitors

Neurotransmitter Agents

Neurotransmitter Uptake Inhibitors

Molecular Mechanisms of Pharmacological Action

Adrenergic Agents

Sympathomimetics

Adrenergic Uptake Inhibitors

Physiological Effects of Drugs

Psychotropic Drugs

Central Nervous System Stimulants

Enzyme Inhibitors

Pharmacologic Actions

Antidepressive Agents, Tricyclic

Autonomic Agents

Therapeutic Uses

Dopamine Agents

Peripheral Nervous System Agents

Central Nervous System Agents

Antidepressive Agents

ClinicalTrials.gov processed this record on October 31, 2008